1. Repository of OAI
Ελληνικά   English  

Browsing by Author Pentheroudakis, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 65 to 84 of 104 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluationFountzilas, G.; Kourea, H. P.; Bobos, M.; Televantou, D.; Kotoula, V.; Papadimitriou, C.; Papazisis, K. T.; Timotheadou, E.; Efstratiou, I.; Koutras, A.; Pentheroudakis, G.; Christodoulou, C.; Aravantinos, G.; Miliaras, D.; Petraki, K.; Papandreou, C. N.; Papakostas, P.; Bafaloukos, D.; Repana, D.; Razis, E.; Pectasides, D.; Dimopoulos, A. M.24-Nov-2015-
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P. A.; Fountzilas, G.; Eleftheraki, A. G.; Kalofonos, H. P.; Pentheroudakis, G.; Skarlos, D.; Dimopoulos, M. A.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Boukovinas, J.; Lambaki, S.; Katirtzoglou, N.; Bakogiannis, C.; Syrigos, K. N.24-Nov-2015-
Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safetyPentheroudakis, G.; Razis, E.; Athanassiadis, A.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictorsPentheroudakis, G.; Fountzilas, G.; Kalofonos, H. P.; Golfinopoulos, V.; Aravantinos, G.; Bafaloukos, D.; Papakostas, P.; Pectasides, D.; Christodoulou, C.; Syrigos, K.; Economopoulos, T.; Pavlidis, N.24-Nov-2015-
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology GroupSkarlos, D. V.; Timotheadou, E.; Galani, E.; Samantas, E.; Grimani, I.; Lianos, E.; Aravantinos, G.; Xanthakis, I.; Pentheroudakis, G.; Pectasides, D.; Fountzilas, G.24-Nov-2015-
Perspectives for targeted therapies in cancer of unknown primary sitePentheroudakis, G.; Pavlidis, N.24-Nov-2015-
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinomaEvans, T. R.; Pentheroudakis, G.; Paul, J.; McInnes, A.; Blackie, R.; Raby, N.; Morrison, R.; Fullarton, G. M.; Soukop, M.; McDonald, A. C.24-Nov-2015-
Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumorsGelderblom, H.; Salazar, R.; Verweij, J.; Pentheroudakis, G.; de Jonge, M. J.; Devlin, M.; van Hooije, C.; Seguy, F.; Obach, R.; Prunonosa, J.; Principe, P.; Twelves, C.24-Nov-2015-
Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemesPentheroudakis, G.; Briasoulis, E.; Karavassilis, V.; Mauri, D.; Tzamakou, E.; Rammou, D.; Pavlidis, N.24-Nov-2015-
Positive urinary cytology in patients with lung cancer in the absence of obvious urine tract metastasesVoulgaris, E.; Pentheroudakis, G.; Pappa, L.; Bafa, M.; Goussia, A.; Dalezis, P.; Tsombanidou, C.; Geromichalos, G.; Papageorgiou, A.; Koutsilieris, M.; Malamou-Mitsi, V.; Pavlidis, N.24-Nov-2015-
The pregnant mother with breast cancer: diagnostic and therapeutic managementPavlidis, N.; Pentheroudakis, G.24-Nov-2015-
Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled studyHalaska, M. J.; Pentheroudakis, G.; Strnad, P.; Stankusova, H.; Chod, J.; Robova, H.; Petruzelka, L.; Rob, L.; Pavlidis, N.24-Nov-2015-
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group StudyFostira, F.; Tsitlaidou, M.; Papadimitriou, C.; Pertesi, M.; Timotheadou, E.; Stavropoulou, A. V.; Glentis, S.; Bournakis, E.; Bobos, M.; Pectasides, D.; Papakostas, P.; Pentheroudakis, G.; Gogas, H.; Skarlos, P.; Samantas, E.; Bafaloukos, D.; Kosmidis, P. A.; Koutras, A.; Yannoukakos, D.; Konstantopoulou, I.; Fountzilas, G.24-Nov-2015-
Probing the unknown in cancer of unknown primary: which way is the right way?Pentheroudakis, G.; Pavlidis, N.24-Nov-2015-
Profiling clinical cancer research across the Atlantic: A review of research and its characteristics presented at ASCO and ESMO Congresses during the last decadePentheroudakis, G.; Krikelis, D.; Cervantes, A.; Vermorken, J.; Pavlidis, N.24-Nov-2015-
Prognostic Factors in Patients With Cancer of Unknown Primary (CUP)Petrakis, D.; Voulgaris, E.; Pentheroudakis, G.; Pavlidis, N.24-Nov-2015-
PROGNOSTIC SIGNIFICANCE OF GENE EXPRESSION PROFILE IN PATIENTS WITH CARCINOMAS OF UNKNOWN PRIMARY (CAUP)Souglakos, J.; Pentheroudakis, G.; Papadaki, C.; Cervantes, A.; Petrakis, D.; Roodriguez-Braun, E.; Lagoudaki, E.; Georgoulias, V.; Mavroudis, D.; Pavlidis, N.24-Nov-2015-
Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynxPentheroudakis, G.; Nicolaou, I.; Kotoula, V.; Fountzilas, E.; Markou, K.; Eleftheraki, A. G.; Fragkoulidi, A.; Karasmanis, I.; Tsigka, A.; Angouridakis, N.; Vlachtsis, K.; Nikolaou, A.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Prognostic utility of beta-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) studyPentheroudakis, G.; Batistatou, A.; Kalogeras, K. T.; Kronenwett, R.; Wirtz, R. M.; Bournakis, E.; Eleftheraki, A. G.; Pectasides, D.; Bobos, M.; Papaspirou, I.; Kamina, S.; Gogas, H.; Koutras, A. K.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group StudyKalofonos, H. P.; Bamias, A.; Koutras, A.; Papakostas, P.; Basdanis, G.; Samantas, E.; Karina, M.; Misailidou, D.; Pisanidis, N.; Pentheroudakis, G.; Economopoulos, T.; Papadimitriou, C.; Skarlos, D. V.; Pectasides, D.; Stavropoulos, M.; Bafaloukos, D.; Kardamakis, D.; Karanikiotis, C.; Vourli, G.; Fountzilas, G.24-Nov-2015-
Showing results 65 to 84 of 104 < previous   next >